Astrazeneca PLC 20-F for FY2020

Headline figures

Fiscal year ended December 31, 2020, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue

$26.62B

up 9.2% from $24.38B a year earlier

Net income

$3.2B

up 139.4% from net income of $1.34B a year earlier

Diluted EPS

$2.44

up 136.9% from $1.03 a year earlier